UBS replaces small caps defector
UBS Global Asset Management (UBS) has moved swiftly to shore up the gap in its small caps team by reassigning senior analyst Mark Buizen as joint portfolio manager alongside existing small cap analyst Kuan Oh.
The pair will jointly manage the assets of the UBS Emerging Companies Fund, which has $20 million in assets under management after launching at the end of March.
Buizen replaces UBS small cap portfolio manager Michael Cowin who left recently to join AMP Capital Investors in its small caps investment team.
Buizen has been with the group for over 8 years, having joined as a material equities analyst from Armstrong Jones Asset Management back in 1996.
Buizen has an aggregate of 20 years industry experience, while Oh, who also has a number of years experience, joined the group five years ago.
UBS announced the move to a forum of research houses and dealer group researchers yesterday in light of Assirt Research placing the Emerging Companies Fund ‘on hold’ earlier in the week after Cowin’s departure was announced.
Other small cap managers to jump ship in recent times include BT Financial Group’s Matt Riordan who left to join boutique small caps firm Paradice Cooper as a portfolio manager.
Last week Macquarie Funds Management also lost two key personnel to ING Australia, with Issam Eid and Steven Ng crossing over and resuled in the group’s small caps capabilities being placed 'on hold' by Assirt.
Recommended for you
AZ NGA’s CEO has unpacked how its recent $345 million debt facility from Barings will accelerate its advice network’s growth ambitions, and allow its largest firms to access a greater source of funding.
Research by Colonial First State has found women are reluctant to make retirement preparations, despite 62 per cent saying they feel that they are unable to achieve a comfortable retirement.
Managed accounts saw net inflows of $14.3 billion in the six months to 31 December, according to the latest IMAP FUM census.
The increased bids for Insignia from Bain and CC Capital value the company at $3.3 billion, while there is still a possibility for competing bids from rival players such as Brookfield.